2018
DOI: 10.2147/ijgm.s187285
|View full text |Cite
|
Sign up to set email alerts
|

The impact of sarcopenic obesity on inflammation, lean body mass, and muscle strength in elderly women

Abstract: ObjectiveThe objective of this study was to apply the newly standardized definition for sarcopenia from the Foundation for the National Institutes of Health (FNIH) and the current definition for obesity to 1) determine the prevalence of sarcopenic obesity (SO) in obese elderly women; 2) compare the muscle strength, lean body mass, and markers of inflammation between obese elderly women with SO and nonsarcopenic obesity (NSO), and 3) elucidate the relationship between appendicular lean mass adjusted for body ma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
11
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(12 citation statements)
references
References 33 publications
(62 reference statements)
1
11
0
Order By: Relevance
“…In our analysis, patients presented similar ages in the OLMM and ONMM groups. BMI was higher in the OLMM group by ASM/BMI, while BMI was negatively correlated with ASM/wt × 100, as well as for ASM/BMI, similarly to another study 25. In addition, the ASM/wt × 100 and ASM/BMI had a negative influence on body mass and were adequate for evaluating LMM in obese individuals.…”
Section: Discussionsupporting
confidence: 78%
“…In our analysis, patients presented similar ages in the OLMM and ONMM groups. BMI was higher in the OLMM group by ASM/BMI, while BMI was negatively correlated with ASM/wt × 100, as well as for ASM/BMI, similarly to another study 25. In addition, the ASM/wt × 100 and ASM/BMI had a negative influence on body mass and were adequate for evaluating LMM in obese individuals.…”
Section: Discussionsupporting
confidence: 78%
“…Importantly, as skeletal muscle plays a critical role in glycaemic control and metabolic homeostasis (74,75), the combination of a loss of lean body mass and a concomitant increase in visceral adiposity will likely exacerbate the risk of developing metabolic disease, particularly in the older adult, accelerating skeletal muscle deterioration, reduced physical performance, an increased risk for disability, hospitalizations, morbidity, and early mortality (76)(77)(78). The development of sarcopenic-obesity is thought to be brought about by a combination of factors that contribute to the development of both conditions (21) and is associated with significantly greater body fat, oxidative stress and inflammation and intracellular lipotoxicity, glucose and endocrine dysregulation, as well as impaired muscle strength and lower lean body mass (63,66,(79)(80)(81). Further, when obesity and impaired muscle function co-exist, they act synergistically in a "vicious cycle" on the risk of developing multiple health-related outcomes (19,21,42,(82)(83)(84).…”
Section: Diagnosis and Prevalence Of Sarcopenic-obesitymentioning
confidence: 99%
“…Thus, the gap in SUA between genders narrowed, which may neutralize the difference in the relationship of hyperuricemia and low SMM association between genders. In addition, adipose accumulation increases the burden of insulin resistance and inflammation and can lead to skeletal muscle loss [44]; it is evident that women have a higher percentage of body fat than age-matched men.…”
Section: Discussionmentioning
confidence: 99%